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Activation of a Nonclassical NKT Cell Subset
in a Transgenic Mouse Model
of Hepatitis B Virus Infection
who developed transgenic mice expressing complete
or partial copies of the HBV genome in the liver (Chisari
and Ferrari, 1995; Chisari et al., 1987, 1986, 1985; Gui-
dotti et al., 1995). Transgenic mice are tolerant to viral
gene products and do not develop liver disease (Wirth
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3 Pathology, and 4 Medicine et al., 1995). However, adoptive transfer of lymphocytes
from syngeneic, HBV-immunized donor mice into suchUniversity of California Medical Center
San Francisco, California 94143 recipients results in both suppression of viral replication
and the induction of liver injury that recapitulates many
features of human hepatitis. These studies not only dem-
onstrated the potential of host immune cells to elicitSummary
tissue damage but have also implicated inflammatory
cytokines released from these cells in the control of viralNKT cells are specialized cells of the immune system
that bear both T cell and NK cell markers. Classical NKT replication (Cavanaugh et al., 1997; Gilles et al., 1992a;
Guidotti and Chisari, 1999; Guidotti et al., 1996; Guilhotcells display TCRs of restricted heterogeneity (V14-
J281) and recognize lipid antigens (e.g., -galactosyl et al., 1993; Tsui et al., 1995).
Prior studies have focused on the role of virus-specificceramide) presented by nonpolymorphic CD1 mole-
cules. Recently, other nonclassical NKT subsets have cytotoxic T lymphocytes (CTLs) isolated from previously
immunized donors as effectors of liver injury in thesebeen recognized, including NKT cells not reactive with
CD1d--galactosyl ceramide complexes. The biologi- models. We sought to examine the potential of other
immune cells to contribute to liver injury and in particularcal functions of these cells are unknown. Here, we
show that nonclassical NKT cells that are CD1d re- wished to explore those cell-mediated responses that
arise when naive (unimmunized and nontolerized) im-stricted but nonreactive to -GalCer are activated in
response to hepatocytes expressing hepatitis B viral mune systems are exposed to infected hepatocytes, as
occurs in acute hepatitis B in vivo. To this end, weantigens in a transgenic mouse model of acute hepati-
tis B virus infection. Our results document the first introduced two modifications into the adoptive transfer
model of Chisari to mimic more closely primary HBVin vivo function for such nonclassical NKT cells and
suggest a role for these cells in the host response to infection. First, HBV-transgenic animals rendered immu-
nodeficient by mutations in the recombinase-activatingHBV infection.
gene (Rag-1) or the T cell receptor (TCR C-) were used
as recipients; this eliminates most or all tolerized im-Introduction
mune elements from recipient mice (Mombaerts et al.,
1992b, 1992a). (Rag-1/ mice lack T and B cells, whileOne of the challenges in understanding viral pathogene-
sis is the elucidation of the full repertoire of immune TCR C-/ mice lack primarily T cells; in both lines,
NK cells and other components of the innate immuneresponses that control the replication of the invading
pathogen. Generally speaking, such control mechanisms system are intact). Second, we reconstituted these mice
with splenocytes from nonimmunized syngeneic do-can be either noncytocidal or cytocidal. Noncytocidal
responses can result from the release of cytokines or nors. In this way, bias introduced by immunization or
by selection for particular immune effector subpopula-other substances with antiviral potential, without neces-
sarily injuring the infected cell. By contrast, cytocidal tions is avoided. Using this system, we here describe
the rapid development of an acute hepatitis that is de-responses aid in suppressing the pathogen but can also
contribute to tissue injury and disease via the killing of pendent upon a nonclassical subset of NKT cells.
infected cells.
Many of these notions derive in part from studies of Results
hepatitis B virus (HBV) pathogenesis. Human HBV is an
important cause of acute and chronic liver injury in vivo Acute and Chronic Hepatitis after Adoptive
and is strongly linked to the development of hepatocellu- Transfer of Naive Splenocytes
lar cancer. Interestingly, its replication affects neither Transgenic mice expressing the large, middle, and small
the viability nor growth of infected cells in culture (Ganem, HBV surface (envelope) antigens (HBV-Env) in the liver
1996). Correlative clinical and pathological studies sug- (Chisari et al., 1987) were backcrossed to immune-defi-
gest that liver injury does not result from viral replication cient (Rag-1/) (Mombaerts et al., 1992b) or T cell re-
directly, but from host immune responses to viral anti- ceptor C- chain-deficient (TCR C-/) mice (Mom-
gens displayed by infected cells (Chisari and Ferrari, baerts et al., 1992a). Following adoptive transfer of naive
1995). Experimental study of such immune responses, splenocytes into these recipients, the ensuing immune
long frustrated by the inability to transmit HBV to immu- responses and pathologic outcomes were monitored.
nologically tractable animal hosts, is now possible ow- As shown in Figure 1A, transfer was followed by the
ing to pioneering studies by Chisari and colleagues, rapid onset of liver injury, as evidenced by a rise in
the serum level of the enzyme alanine aminotransferase
(ALT), which is released from injured or necrotic hepato-5 Correspondence: ganem@cgl.ucsf.edu
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Figure 1. Acute and Chronic Hepatitis after
Adoptive Transfer of Naive Splenocytes
(A) HBV-EnvRag-1/mice and HBV-Env
TCR C-/ mice develop an acute and
chronic hepatitis after adoptive transfer of
syngeneic, naive splenocytes. HBV-Env-
transgenic mice on a B10.D2 genetic back-
ground (Chisari et al., 1987) were crossed with
either B10.D2 Rag-1/ mice or B10.D2 TCR-
/ mice to generate mice that carry the
HBV-Env transgene in their liver in the ab-
sence of endogenous B cells and T cells (Rag-
1/) or in the absence of endogenous T cells
(TCR C-/). Naive, syngeneic splenocytes
(1  108 cells, minus red blood cells) were
adoptively transferred into male mice (6–10
weeks of age) intravenously. Animals were
bled at regular intervals, and serum alanine
aminotransferase (ALT) was measured as an
indicator of liver injury. As a control for HBV
specificity and for alloreactivity, naive, synge-
neic splenocytes were also adoptively trans-
ferred into either Rag-1/ or TCR C-/
mice without the HBV transgene. Each exper-
imental group had at least five mice.
(B) Histologic evidence of acute hepatitis in
Rag-1/  HBV-Env mice but not Rag-1/
mice, 3 days after adoptive transfer of synge-
neic splenocytes. Liver tissue was fixed in
10% neutral-buffered formalin, paraffin em-
bedded, sectioned (5 m), and stained with
hematoxylin and eosin. Size bar  250 m.
Arrows point to inflammatory infiltrate sur-
rounding portal triads with necrotic hepato-
cytes (asterisk).
(C) HBV-Env  Rag-1/ mice develop an
acute and chronic hepatitis after adoptive
transfer of syngeneic, naive splenocytes (1 
108 cells).
cytes. The ALT rise began as early as 2–3 days after elevation (Figure 1A) and by persistent histologic signs
of inflammation (data not shown). These kinetics sug-adoptive transfer; these rapid kinetics suggest that an
innate immune response to the target cells is responsi- gest that this second phase of the illness may be due
to adaptive immune responses to HBV. Both forms ofble for at least a component of the injury. Liver tissue
harvested at this time revealed histologic evidence of injury were dependent on viral antigen expression, since
transfer of splenocytes into Rag-1/ mice or TCRlobular inflammation and hepatocellular damage (Figure
1B). Subsequently, the recipient animals develop a C-/ without the HBV envelope transgene did not in-
duce liver injury (Figure 1). Compilation of ALT resultschronic hepatitis, characterized by sustained serum ALT
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Figure 2. Acute Hepatitis Is Induced Only
When Transferred Cells Have a Rearranged
/ T Cell Receptor
HBV-Env  TCR C-/ mice develop acute
hepatitis following adoptive transfer of donor
splenocytes (1  108 ) from syngeneic wild-
type (B10.D2) but do not develop acute hepa-
titis when the donor splenocytes are from
syngeneic Rag-1/ mice (Rag/ B10.D2) or
syngeneic TCR C-/ mice (TCR C-/
B10.D2).
from three experiments after adoptive transfer of synge- the HBV-transgenic Rag-1/ recipients, as compared
to that observed in the intrahepatic lymphocyte poolneic, naive splenocytes demonstrates that these results
are highly significant: 16/18 HBV-EnvTCR C-/mice from nontransgenic Rag-1/ recipients (45% versus
11%; p 0.05) (Figures 3A and 3B). Most of these recov-and 13/13 HBV-Env Rag-1/ mice developed hepati-
tis as compared to 0/11 TCR C-/ mice or 0/12 Rag- ered NK1.1 T cells express the V8 TCR (Figure 3C),
consistent with the prominent usage of V8 among1/ mice (Fisher’s exact test: two-sided P value
is 0.0001) (data not shown). NKT cells compared to conventional  T cells in this
mouse strain (Bendelac et al., 1997; Benlagha et al.,The acute hepatitis was not the result of the expansion
of effector populations in the recipient liver owing to 2000). Furthermore, the NKT cells eluted from the livers
of HBV-Env  Rag-1/ mice with acute hepatitis wereenhanced “replication space” resulting from the Rag/
mutation. As shown in Figure 1C, when splenocytes clearly activated, since ELISpot assays (Figures 6B and
6C), as well as intracellular cytokine staining (data notwere transferred from unimmunized B10D2 mice into
Rag Env B10.D2 recipients, hepatitis developed with shown), revealed that the eluted cells were specifically
producing interferon-	 and IL-4. In contrast, fewer thansimilar kinetics and severity as in the Rag/ animals.
As before, this lesion was dependent upon the presence 0.1% of the cells eluted from the livers of Rag/ mice
3 days after adoptive transfer of syngeneic, naive splen-of viral antigens, as nontransgenic B10.D2 recipients
experienced no ALT elevation throughout the course of ocytes were producing either IFN-	 or IL-4. Together,
these data support the hypothesis that NKT cells arethe experiment.
specifically activated in the mice which carry the HBV-
Env transgene, since the Rag-1/ mice that receivedAcute Hepatitis Is Induced Only When Transferred
identical cells had many fewer NKT cells in their livers,Cells Have a Rearranged TCR
and the great majority of these cells were not activated.Additional transfer experiments (Figure 2) revealed that
Rag/ donor cells, which contain normal levels of NK
cells but lack T cells, B cells, NK1.1 T cells, and 	
 Sorted NKT Cells Mediate Acute Hepatitis
cells, did not produce injury (0/5 mice developed acute We next fractionated donor spleen cells into NK1.1
hepatitis). Similarly, TCR C-/ donor cells, which con- and NK1.1 populations and transferred these cells into
tain normal levels of NK cells, B cells, and 	
 cells but HBV-transgenic Rag-1-deficient recipients. Consistent
lack / T cells and NK1.1 T cells, also did not produce with a role for NKT cells, depletion of NK1.1 cells ab-
liver injury (0/7 mice developed acute hepatitis) (Figure lates the early acute hepatitis, while enrichment for these
2). These experiments, taken together with the rapid cells augments tissue damage (Figure 4A). Specifically,
kinetics of disease onset, suggest natural killer T cells the mice that received 1  108 splenocytes depleted of
(NK1.1 T cells, or NKT cells) are likely effector(s) of this NK1.1 cells had only a trivial increase in their baseline
acute hepatitis. ALT (21%) 2 days after adoptive transfer, while mice
that received 1  108 unsorted syngeneic splenocytes
or 2  106 NK1.1-positive sorted splenocytes had aThe Number of NKT Cells Is Greatly Increased in HBV-
Transgenic Mice with Acute Hepatitis but Not 146% and 391% increase over baseline ALT, respec-
tively.in Mice that Do Not Carry the HBV Transgene
To explore further the potential role of NKT cells in medi- Although the NK1.1-enriched population includes
both NK cells and NK1.1 T cells, our prior studies withating the early liver injury, we characterized lymphocytes
eluted from the livers of transgenic animals with hepati- Rag/ and TCR/ donors (Figure 2) suggested that NK
cells, which are not affected by these gene deletions,tis. Two days after adoptive transfer of naive spleen cells
into HBV-transgenic Rag-1/ or nontransgenic Rag1/ did not contribute to liver injury. To confirm these find-
ings, we separated cells bearing both NK1.1 and TCRmice, flow cytometric analysis revealed a significant in-
crease in the proportion of NK1.1 T cells in the livers of markers (NKT cells) from cells positive for NK1.1 alone
Immunity
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Figure 3. The Number of NKT Cells Is Greatly Enriched In HBV-Transgenic Mice with Acute Hepatitis
Rag-1/ HBV-Env mice have increased numbers of NK1.1 T cells in their livers (45%), 2 days after adoptive transfer of syngeneic splenocytes
(B), as compared to similarly adoptively transferred Rag-1/ mice (11%) (A). The majority of these NK1.1 T cells use V8 as their TCR  chain
(C). Mice were injected with naive, syngeneic splenocytes as described. Lymphocytes were isolated from the animals by perfusion and gradient
isolation as described. Each experimental group of cells (e.g., Rag/ or HBV-Env  Rag/) represents pooled lymphocytes from the livers
of five mice. Cells were stained by standard protocol with fluorescent-tagged antibodies (NK1.1-FITC, H57-PE, and F23.1-PE). The figure
represents one of three experiments. Note that infiltrating NKT cells display a bimodal distribution of NK1.1 levels. This likely reflects the fact
that levels of NK1.1 decrease when NKT cells are activated (Chen et al., 1997).
(NK cells) using sterile cell sorting and tested each sub- tive and -negative populations using sterile cell sorting
and tested each subpopulation by adoptive transfer intopopulation by adoptive transfer into HBV-Env-trans-
genic Rag/ recipients. Mice that received 1.2  106 HBV Env-transgenic Rag/ recipients. As shown in Fig-
ure 5D, acute hepatitis segregated with the CD1d-NKT cells developed a severe hepatitis as evidenced by
a large increase in serum ALT (2600% over baseline -GalCer tetramer-negative population (5/5 mice devel-
oped acute hepatitis) and not with the CD1d--GalCerALT; Figure 4B) and by histologic evidence of severe
lobular inflammation and hepatocellular necrosis (Figure tetramer-positive population (0/5 mice developed acute
hepatitis). Thus, the NKT cells that mediate the acute4C). By contrast, the mice that received 1.2  106 NK
cells displayed no increase in serum ALT (Figure 4B) hepatitis do not recognize -GalCer presented by CD1d.
and little or no abnormality in liver histology (Figure 4C).
Taken together, these data demonstrate that NKT cells Acute Hepatitis Is CD1d Dependent but Not Mediated
are both necessary and sufficient to induce acute hepa- by TCR V14 NKT Cells
titis in this model. To test whether the NKT cells involved in the acute
hepatitis used the invariant V14 T cell receptor, we
used mice transgenic for the V14 T cell receptor,NKT Cells that Mediate Acute Hepatitis Do Not Bind
CD1d--Galactosylceramide Tetramers crossed with the TCR C-/mice, as splenocyte donors
in adoptive transfer experiments into HBV-Env-trans-We next sought to characterize the NKT cells involved
in mediating the acute hepatitis. The largest group of genic  Rag-1/ recipients. By using these mice as
splenocyte donors, we increased the number of V14NKT cells express an invariant V14 T cell receptor
specific for the lipoglycan -galactosylceramide NKT cells transferred by at least 7-fold and eliminated
any other T cells or NKT cells that do not express the(-GalCer), presented by CD1d. Surprisingly, the vast
majority of NK1.1 TCR cells eluted from the livers of V14 TCR (Bendelac et al., 1996). Despite the vast in-
crease in V14 NKT cells in the adoptive transfer, themice with acute hepatitis were CD1d--GalCer tetramer
negative, as assessed using CD1d tetramers loaded HBV-Env-transgenic Rag/ recipients developed little
or no early acute hepatitis (1/8 mice developed mildwith -GalCer (Benlagha et al., 2000; Matsuda et al.,
2000) (Figures 5A and 5B). Furthermore, the majority of hepatitis), as compared to the accompanying transfer
of WT splenocytes (8/8 mice developed acute hepatitis)NKT cells eluted from the livers were both CD4 and CD8
negative (data not shown). In contrast, 24% of lympho- (Fisher’s exact test: two-sided P value  0.001) (Figure
6). Thus, canonical V14 NKT cells are not sufficientcytes eluted from the livers of wild-type B10.D2 mice
were tetramer-positive cells, consistent with prior stud- to induce acute hepatitis in HBV-Env-transgenic Rag-
1/ mice. This result confirmed our earlier suspicionies (Benlagha et al., 2000; Matsuda et al., 2000) (Figure
5C); this indicates that our techniques for -GalCer/CD1 that the NKT cells involved in the acute hepatitis are
predominantly TCR V14 negative and are therefore dis-binding have the appropriate sensitivity.
It is possible that the NKT cells eluted from the livers of tinct from classical NKT cells.
In view of the importance of CD1d molecules in pre-HBV-Env Rag-1/ with acute hepatitis were tetramer
positive before activation but lost staining due to TCR sentation of antigens to NKT cells, we sought to deter-
mine whether CD1d functioned in any role in mediatingdownregulation. To test this possibility, we separated
naive splenocytes into CD1d--GalCer tetramer-posi- the acute hepatitis. HBV-Env-transgenic Rag/ recipi-
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Figure 4. NKT Cells but Not NK Cells Mediate
Acute Hepatitis
(A) Rag-1/  HBV-Env mice develop acute
hepatitis when the donor splenocytes are
from syngeneic wild-type mice (1  108 cells)
or syngeneic splenocytes positively sorted
for NK1.1 (2  106 cells) but do not develop
acute hepatitis when syngeneic donor splen-
ocytes have been depleted of NK1.1-positive
cells (1 108 cells). B10.D2 splenocytes were
isolated, red blood cells were lysed, and cells
were stained with an FITC-conjugated anti-
body to NK1.1. Cells were then fractionated,
using a MoFlo FACS, into NK1.1 and NK1.1
populations. These two populations were im-
mediately transferred intravenously into Rag-
1/  HBV-Env mice. ALT values represent
an average of five mice.
(B) Rag-1/  HBV-Env mice develop acute
hepatitis when donors cell are NK1.1 T cells
but do not develop acute hepatitis when do-
nor cells are NK cells. Splenocytes were iso-
lated as above and stained with antibodies
against NK1.1 and the T cell receptor chains
V8, V7, and V2 (these TCRs represent ap-
proximately 85% of the TCR  chains used
by NK1.1 T cells). Populations of cells were
collected that were either singly positive for
NK1.1 (NK cells) or doubly positive for NK1.1
and TCR (NK1.1 T cells). These cells were
immediately transferred intravenously into
Rag-1/  HBV-Env mice. The ALTs of indi-
vidual mice and also the mean of the experi-
mental groups are represented.
(C) Histologic features of normal liver (animals
receiving NK cells) or acute hepatitis (animals
receiving NK1.1 T cells) 8 days after adoptive
transfer are shown using a hematoxylin and
eosin stain.
ents were rendered CD1d null by crossing them to of these cytokines seen during acute hepatitis is almost
absent if these mice are rendered CD1d null (FiguresCD1d/mice (Mendiratta et al., 1997), and animals were
reconstituted with syngeneic, naive splenocytes. As 6B and 6C). Thus, the NKT cells that mediate the acute
hepatitis are not functional in the absence of CD1d.shown in Figure 6A, HBV-Env- transgenic Rag/ mice
deficient in CD1d do not develop acute hepatitis (0/8
mice developed acute hepatitis), as compared to simi- Acute Hepatitis Develops in HBV-Env Rag/ Mice
after Adoptive Transfer of Syngeneic Lymphocyteslarly treated HBV-Env-transgenic Rag/ mice (8/8 mice
developed acute hepatitis following adoptive transfer). Eluted from Wild-Type Livers
To test whether the NKT cells that mediate acute hepati-Furthermore, production of interferon-	 and IL-4 by lym-
phocytes eluted from livers of HBV-Env  Rag/ mice tis are present in the liver despite the fact that they do
not express the V14 TCR, we used lymphocytes elutedafter adoptive transfer of syngeneic splenocytes is de-
pendent on the presence of CD1d, since the production from the livers of WT B10.D2 mice in adoptive transfer
Immunity
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Figure 5. The NK1.1 T Cells that Mediate Acute Hepatitis Are CD1d--Galactosylceramide Tetramer Negative
NK1.1 T cells eluted from Rag-1/  HBV-Env mice 2 days after adoptive transfer of syngeneic splenocytes are CD1d--galactosylceramide
tetramer negative.
(A) 56% of the cells eluted from the livers of Rag-1/  HBV-Env mice with acute hepatitis, 2 days after adoptive transfer of syngeneic
splenocytes, are NK1.1, T cell receptor positive.
(B) Only 4% of these NK1.1 T cells are CD1d--galactosylceramide tetramer positive.
(C) 24% of lymphocytes eluted from wild-type B10.D2 livers are CD1d--galactosylceramide tetramer positive. Lymphocytes were isolated
from the animals as described. Each experimental group of cells (e.g., HBV-Env  Rag/ or WT B10.D2) represents pooled lymphocytes
from the livers of five mice. Cells were stained by standard protocol with fluorescent-tagged antibodies (NK1.1-FITC, H57-PE) and the CD1d-
-galactosylceramide tetramer. The figure represents one of four experiments.
(D) Acute hepatitis is mediated by CD1d tetramer-depleted splenocytes but not by CD1d tetramer-enriched splenocytes. B10.D2 splenocytes
were isolated, red blood cells were lysed, and cells were stained with a PE-labeled CD1d--galactosylceramide tetramer. Cells were then
fractionated using a MoFlo FACS into tetramer and tetramer populations. These two populations were immediately transferred intravenously
into Rag-1/  HBV-Env mice: 1  108 tetramer, or total splenocytes cells/mouse; 2  106 tetramer cells. ALT values represent an average
of five mice.
experiments. As seen in Figure 6D, acute hepatitis devel- the responses to splenocytes adoptively transferred into
mice bearing intact, replication-competent HBV trans-ops in HBV-Env Rag/ mice after adoptive transfer of
approximately 100-fold fewer syngeneic lymphocytes genes. We initiated these experiments because the
HBV-Env-transgenic mice express only a subset of viraleluted from WT livers as compared to the standard num-
ber lymphocytes transferred from WT spleens in all the genes, do not display viral replication, and as such do
not allow exploration of the antiviral aspects of the im-previous experiments (1  108 ). Thus, cells that can
mediate acute hepatitis are present in significant num- mune responses under study. In addition, since they
overexpress one of the three isoforms of HBV envelopebers in the liver.
proteins (the large or L protein) which is retained in
the endoplasmic reticulum (ER), these mice display anAcute Hepatitis in HBV-Replication  Rag/ Mice
after Adoptive Transfer of Syngeneic Splenocytes increased sensitivity to IFN-	 (Gilles et al., 1992b; Gui-
dotti et al., 1995) and thus may have exaggerated ALTIn order to assess the relevance of our observations to
responses to authentic HBV infection, we characterized rises in response to production of this cytokine. In fact,
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Figure 6. The NKT Cells that Mediate Acute Hepatitis Are CD1d Restricted and Present in High Frequency in the Liver but Are Not TCR V14
Positive
(A) HBV-Env  Rag-1/ mice develop an acute hepatitis after adoptive transfer of syngeneic, naive splenocytes from WT B10.D2 mice but
do not develop acute hepatitis if splenocyte donors are B10.D2, TCR V14 Tg  TCR C-/, or B10.D2, TCR C-/. HBV-Env  Rag-1/ 
CD1d/ or Rag-1/ mice on a B10.D2 background do not develop acute hepatitis after adoptive transfer of syngeneic, naive splenocytes
from WT B10.D2 mice. ALT values represent an average of at least seven mice.
(B and C) ELISpot analysis of eluted liver lymphocytes reveals that HBV-Env  Rag/ mice have a 10-fold increase in the percent of 	
interferon-producing cells and a 7-fold increase in the percent of IL-4-producing cells in their livers 3 days after adoptive transfer of syngeneic
splenocytes, as compared to similarly adoptively transferred Rag-1/ mice or HBV-Env  Rag-1/ mice which are CD1d null (CD1d/).
(D) HBV-Env  Rag/ mice develop acute hepatitis after adoptive transfer of 1.5  106 syngeneic lymphocytes eluted from WT livers, as
compared to adoptive transfer of lymphocytes from WT spleens.
we initiated our studies of HBV immune responses in HBV replication, express all viral proteins at their proper
stoichiometry, and do not display enhanced sensitivitythese mice precisely because this sensitivity gave us
a simple readout (ALT release) that would reflect the to the toxic effects of IFN-	 (Guidotti et al., 1995).
As shown in Figure 7, adoptive transfer of syngeneicintrahepatic production of this cytokine. In contrast, the
HBV-replication-transgenic mice display intrahepatic splenocytes into the HBV-replication  Rag/ mice re-
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Figure 7. Adoptive Transfer of Syngeneic
Splenocytes into C57/BL6 HBV-Replica-
tion Rag/ Mice Results in Acute Hepatitis
as well as Accumulation and Activation of
NKT Cells in the Liver
(A) C57/BL6 HBV-replication  Rag/ mice
develop acute hepatitis following adoptive
transfer of donor splenocytes from syngeneic
wild-type mice (1  108 cells).
(B) Histologic evidence of acute hepatitis in
HBV-replication  Rag/ mice, 2 days after
adoptive transfer of syngeneic splenocytes.
The figure presents representative hepatic le-
sions from two mice. Size bar  75 m.
Arrows point to inflammatory infiltrate with
necrotic hepatocytes.
(C) HBV-replication  Rag/ mice have in-
creased numbers of NK1.1 T cells in their liv-
ers (13%), 2 days after adoptive transfer of
syngeneic splenocytes, as compared to simi-
larly adoptively transferred Rag-1/ mice
(3%). There was a 2-fold increase in the
absolute number of cells eluted from HBV-
replication  Rag/ livers. Each experimen-
tal group of cells represents pooled lympho-
cytes from the livers of three mice.
(D) ELISpot analysis of eluted liver lympho-
cytes reveals that HBV-replication  Rag/
mice have a 3-fold increase in the percent of
	 interferon-producing cells in their livers 3
days after adoptive transfer of syngeneic
splenocytes, as compared to similarly adop-
tively transferred Rag-1/ mice.
NKT Cell Activation in Response to HBV Infection
591
sults in acute hepatitis as well as accumulation and addition, NK1.1-negative populations that bind -GalCer/
CD1 tetramers have been described. Beyond these phe-activation of NKT cells in the liver. Specifically, a similar
notypic characterizations, however, little is known of thebiphasic ALT rise that is seen in the HBV-Env  Rag/
in vivo roles of any of these newly described NKT sub-mice is again observed (Figure 7A), but as expected,
sets in immune regulation or disease pathogenesis.the ALT rise is much more modest than that seen in the
The results presented in this paper demonstrate a roleEnv mice—typically, serum transaminases were ele-
for NKT cells—a population of cells which straddle thevated no more than 2-fold above background. Liver tis-
innate and adaptive immune system—in the responsesue harvested at this time revealed histologic evidence
to infection by a human viral pathogen. In addition, theyof lobular inflammation and necrosis in 12/12 mice be-
reveal that the NKT cells involved in this response repre-ginning 2 days after adoptive transfer; 10/10 Rag-1/
sent a subpopulation of NKT cells (CD1d restricted, V14mice lacking the HBV transgene showed no evidence
negative, and unable to recognize -GalCer), whose exis-of inflammation or necrosis 2 days after adoptive trans-
tence has been recognized only recently and whosefer of syngeneic splenocytes (Fisher’s exact test: two-
biological functions have hitherto been obscure. Oursided P value is 0.0001). Figure 7B shows representa-
findings raise several provocative mechanistic ques-tive hepatic lesions from two HBV-replication  Rag/
tions and provide an experimental system in which theymice, 2 days after adoptive transfer. When the eluted
can be addressed. First, what is the nature of the mole-cells were examined by flow cytometry for NKT cells,
cule being presented by CD1d and recognized by thesethere was a 4-fold increase in the fraction of cells in the
NKT cells in HBV-positive livers? While NKT cells areHBV-transgenic liver that displayed NKT cell markers.
known to recognize hydrophobic ligands, the exact na-Moreover, there was a 2-fold increase in the absolute
ture of the target(s) in the liver is unknown. Two classesnumber of cells eluted from these livers (Figure 7C),
of possibilities exist. First, the target might be virus en-indicating a significant increase in the total number of
coded —candidates would include the myristate moietyinfiltrating NKT cells in this setting. Furthermore, when
of the large envelope protein or hydrophobic peptidescells were eluted from the livers of these mice at day 3
from the HBV envelope protein. This would be similarpost adoptive transfer, a clear increase in the number
to the ability of nonpolymorphic MHC Ib H2-M3 mole-of IFN-	-producing cells was observed, as determined
cules to bind and present N-formylated peptides of bac-by ELISpot analysis; this increase was dependent upon
terial origin (Chiu et al., 1999). Alternatively, HBV genethe presence of the viral genome (Figure 7D). Thus, simi-
expression could lead to enhanced presentation of en-lar processes are at work in the context of replicating
dogenous hydrophobic ligands—e.g., host lipids or gly-HBV genomes, though, as expected, the severity of the
colipids—by CD1, or sensitize NKT cells to activationimmediate liver injury in this context is lower.
by a given quantity of such ligands. The latter model
would be consistent with the observation that manyDiscussion
NKT cells are autoreactive (Bendelac et al., 1997). Other
viral infections are known to influence activation of in-NKT cells are a specialized subpopulation of T cells that
nate immune effectors—for example, CMV infection
coexpress receptors of the natural killer lineage (e.g.,
leads to the upregulation of MIC (a distant homolog of
NK1.1) and TCRs. Classical NKT cells express a re-
MHC class I which is a ligand for the NK cell stimulatory
stricted TCR repertoire; most express a canonical V14
receptor NKG2D) on infected cells (Groh et al., 2001).
receptor that is conserved between mice and humans, In either case, the infected cell would be presenting an
paired with a limited number of V chains, primarily V8 activation signal alerting the immune system that an
(Bendelac et al., 1997). Classical NKT cells are selected infection has occurred and mobilizing an immediate re-
by the nonpolymorphic MHC-like class I molecule, CD1d sponse, in much the same way that interferon is released
(CD1.1 in mouse), which contains a large hydrophobic upon viral infection, mobilizing antiviral defenses in sur-
binding cleft capable of presenting lipid or other hy- rounding uninfected cells.
drophobic antigens (Porcelli and Modlin, 1999). Indeed, In both lineages of transgenic mice we have exam-
NKT cells can be activated by CD1-restricted display of ined, the NKT cell response results in liver cell injury
a variety of lipids, including cell wall antigens of myco- and could thus contribute to viral pathogenesis. While
bacteria and galactosylceramide from sea sponges. classical NKT cells have also been implicated in experi-
NKT cells display an activated phenotype and are capa- mental liver cell injury mediated by the experimental
ble of rapid expression of cytokines, including IFN-	 administration of concanavalin A (Kaneko et al., 2000)
and IL-4, providing early help for other effector cells and or -GalCer-activated cells (Kakimi et al., 2000), this is
potentially regulating differentiation of some adaptive the first demonstration that NKT cells are activated by
immune responses. Classical NKT cells are enriched in a naturally occurring liver pathogen in vivo and can play
the intrahepatic lymphocyte pool (where they represent a role in liver injury mediated by such a pathogen. Fur-
30%–50% of resident lymphocytes, as compared to thermore, this in vivo activation and liver injury is medi-
0.5% of splenocytes and 0.1% of peripheral lymph ated by a novel, nonclassical NKT cell population.
nodes) (Bendelac et al., 1997). In addition to their role in injury, activated NKT cells
Recent evidence suggests that subsets of NKT cells are known to release large quantities of IFN-	, a cytokine
likely exist. Using CD1 tetramers loaded with -GalCer, known to inhibit HBV replication in vivo. Such release
subpopulations of noncanonical NKT cells have been may also contribute to the noncytolytic clearance of
identified that fail to recognize this complex (Behar and virus from surrounding hepatocytes and recruitment of
Cardell, 2000), in contrast to classical NKT cells which lymphomononuclear inflammatory cells, as earlier dem-
onstrated for cytokines released from intrahepatic CTLsdirectly bind this glycolipid in the context of CD1d. In
Immunity
592
crossed with homozygous RAG-1 KO or TCR- KO mice to obtainor adoptively transferred -GalCer-activated classical
mice heterozygous for the Envelope transgene and homozygous forNKT cells (Guidotti et al., 1996; Kakimi et al., 2001). In
the Rag-1 KO or TCR- KO mutation on a B10.D2 background.fact, given the modest degree of liver injury observed
Heterozygous HBV-replication mice were similarly crossed with
in the mice harboring replicating HBV genomes, this Rag-1 KO mice on a C57/BL6 background to obtain heterozygous
may be the primary role of this response in authentic HBV-replication  homozygous Rag-1 KO mice. CD-1d KO mice
on a C57/BL6 background (generously provided by Luc Van Kaer,hepatitis B. In a recent study of acute HBV infection in
Vanderbilt University) (Mendiratta et al., 1997) were crossed withprimates, levels of intrahepatic viral DNA decline by 90%
B10.D2 mice to obtain mice on a B10.D2 background (H-2d). Thesewell in advance of the peak influx of antigen-specific
mice were then crossed with the B10.D2 heterozygous HBV-Env CTLs in the liver (Guidotti et al., 1999). Such a drop
homozygous Rag-1 KO mice. The offspring of this mating were bred
would be compatible with the rapid mobilization of to obtain the B10.D2 heterozygous HBV-Env  homozygous Rag-1
NKT cells, as modeled here in mice. Although our results KO  homozygous CD1d KO mice. V14-transgenic mice crossed
with TCR C-/ mice on a C57/BL6 background (Bendelac et al.,are limited to work with HBV, the enrichment of NKT cells
1996) were crossed with B10.D2 mice to obtain mice on a B10.D2in the lymphocyte populations of normal mouse and
background (H-2d). All mice are kept in a specific pathogen-freehuman liver leads us to speculate that NKT cells may
facility at UCSF.have evolved to play a more general role in the defense
against hepatic pathogens. Consistent with this,
Cell Sorting and Cell Transfer Experiments
NKT cells in the liver have been found to expand or Donor splenocytes from male mice 6–10 weeks old were obtained
disappear (presumably due to activation-induced cell by rupturing the lymphoid organ following conventional procedures.
death) in animal models of Listeria, malaria, and lympho- Red blood cells were lysed with ammonium chloride, and the re-
maining cells were washed with PBS, counted, filtered through acytic choriomeningitis virus infection (Emoto et al., 1997;
nylon membrane, and then injected intravenously. NK1.1 cells wereHobbs et al., 2001; Pied et al., 2000). Furthermore, in
stained and purified first using Fc block, 1:5 (Unkeless, 1979), toour experimental model of hepatitis B virus infection,
block non-antigen-specific binding of immunoglobulins Fc	 II and III
acute hepatitis develops in HBV-Env Rag/ mice after receptors, then using an FITC-labeled antibody to NK1.1 (Yokoyama
adoptive transfer of approximately 100-fold fewer syn- and Seaman, 1993) and a MoFlo cell sorter (Cytomation, Inc., Ft.
geneic lymphocytes eluted from WT livers as compared Collins, CO). Sorted populations were 95% pure. NK1.1 T cells
were separated from NK cells using Fc block, then an FITC-labeledto lymphocytes from WT spleens, suggesting that func-
antibody to NK1.1 and PE-labeled antibodies to the T cell receptortional NKT effectors are enriched in this organ.
 chains V 8, 7, and 2. (NK1.1 [Yokoyama and Seaman, 1993], F23.1Beyond its immediate role as an antiviral defense
[Staerz et al., 1985], TR310 [Okada et al., 1990], and B20.6 [Necker
mechanism designed to restrict HBV replication, mobili- et al., 1991], PharMingen, San Diego, CA). Cells were 93% pure.
zation of NKT cells in HBV-infected liver may modulate CD1d--GalCer tetramers were generously provided by Mitch Kro-
the nature of the later adaptive response through cyto- nenberg (LIAI, La Jolla, CA). Tetramer staining of lymphocytes was
done according to standard protocol (Matsuda et al., 2000), andkine production. The fact that the early NKT-mediated
staining and cell sorting experiments were performed with a PE-injury evolves in this model into a more chronic hepatitis
labeled tetramer using the MoFlo cell sorter. Cell populationsallows investigations of the influence of the early
were 98% pure. Cells were adoptively transferred as mentioned.
NKT cell response on the subsequent evolution of hepa-
titis. By allowing access to this and other questions, the Disease Model
system described here should not only inform the study Various mice (male, 6–10 weeks of age) were intravenously injected
of the pathogenesis of chronic hepadnaviral infection with cell populations described. Mice were bled by tail vein at de-
scribed intervals, and serum was collected. The mouse serum wasbut also enhance our understanding of the fundamental
used to obtain ALT values as follows: Figure 1: 25 l of mousebiology of NKT cells.
serum was used in a manual Sigma Diagnostics assay for ALT. The
enzymatic reaction was run at room temperature (23C). Note: theExperimental Procedures
values obtained from this assay are lower than those in all other
figures, which were run by a standardized, automated machine atMice
37C. Figures 2, 4, 5, and 6: 100 l of mouse serum was run on aB10.D2 and C57/Bl 6 mice were purchased from Jackson Labora-
Beckman synchon LX 20 to determine serum ALT. Mice were sacri-tory, Bar Harbor, ME. HBV-transgenic mice used include HBV-Env:
ficed at the described time points and livers were collected formouse lineage 107-5D (official designation Tg[Alb-1.HBV] Bri66; in-
histology.bred B10.D2, H-2d) (Chisari et al., 1987) and HBV-replication: lineage
1.3.46 (official designation, Tg [HBV 1.3 genome] chi46) (Guidotti et
al., 1995). The HBV-Env mice contain the entire HBV envelope coding Preparation of Liver Lymphocytes
Intrahepatic lymphocytes were isolated as previously describedregion (subtype ayw) under the constitutive transcriptional control
of the mouse albumin promoter. These mice express the HBV small, (Dao et al., 1998). In brief, animals were perfused via the portal
vein with digestion medium (RPMI medium containing 0.2 mg/mlmiddle, and large envelope proteins in their hepatocytes. The HBV-
replication mice contain a terminally redundant HBV DNA construct collagenase and 0.02 mg/ml DNase, and 5% FCS). After perfusion,
we homogenized the livers by forcing them through a metal strainer;(Guidotti et al., 1995). These mice have high-level viral replication
in their hepatocytes and in the proximal convoluted tubules of their the livers were then digested with digestion buffer at 37C for 45 min.
The cell preparation was then centrifuged to remove hepatocyteskidneys. The replication level seen in these animals is comparable
to that observed in the infected livers of patients with chronic persis- (30 RCF for 3 min), and the remaining cells were centrifuged in a
metrizamide gradient to obtain the lymphocytes. Cells were stainedtent HBV hepatitis, but the mice show no evidence of cytopathology
(Guidotti et al., 1995). by standard protocol (Colligan et al., 1999) first with Fc-block 1:5
(Unkeless, 1979) and then with fluorescent-tagged antibodiesRag-1 KO mice (Mombaerts et al., 1992b) and TCR- KO mice
(Mombaerts et al., 1992a) were obtained on a C57BL/6 background. (NK1.1 [Yokoyama and Seaman, 1993], H57 [Kubo et al., 1989], F23.1
[Staerz et al., 1985]; PharMingen, San Diego, CA) or CD1d--GalCerIn addition, mice were backcrossed for at least ten generations with
B10.D2 mice. Heterozygous B10.D2 HBV-Env mice were crossed tetramers (Matsuda et al., 2000). Fluorescently labeled isotype-
matched nonbinding antibodies were used as negative controls inwith homozygous Rag-1 KO mice or homozygous TCR- KO mice
on a B10.D2 background. The offspring of this cross, heterozygous all experiments since the level of TCR and NK1.1 is low, especially
on activated cells. FACS analysis was done on a Beckman FACSCal-HBV-Env  heterozygous Rag-1 KO or TCR- KO mice, were back-
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ibur or a MoFlo cell sorter (Cytomation, Inc., Ft. Collins, CO). Analysis receptive state and traffics to the cell surface in the presence of
N-formylated peptides. J. Exp. Med. 190, 423–434.of data was done using Cellquest software.
Colligan, J.E., Margulies, D., Shevach, E., and Strober, W. (1999).
ELISpot Assay Current Protocols in Immunology (New York: John Wiley and Sons).
Liver lymphocytes were eluted from various mice 2 and 3 days Dao, T., Mehal, W.Z., and Crispe, I.N. (1998). IL-18 augments per-
after adoptive transfer. Without any further stimulation, cells were forin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161,
counted and immediately plated in triplicate in an anti-cytokine pre- 2217–2222.
coated PVDF- backed 96-well microplate (R&D Systems ELISpot
Emoto, Y., Emoto, M. Kaufmann, S.H. (1997). Transient control of
mouse IFN-	 and IL-4 kits). Seven serial 2-fold dilutions of cells
Interleukin-4-producing Natural Killer T cells in the livers of Listeria
were made for each triplicate. Plates were incubated and developed
monocytogenes-infected mice by interleukin-12. Infect. Immun. 65,
according to the kit protocol, and spots were counted manually
5003–5009.
using a stereomicroscope.
Ganem, D. (1996). Hepadnaviridae and their Replication. In Fields
Virology, 3rd Edition (Philadelphia: Lippincott Williams and Wilkins).Histology
Gilles, P.N., Fey, G., and Chisari, F.V. (1992a). Tumor necrosis factorLivers were removed from animals. Liver pieces were placed in 10%
alpha negatively regulates hepatitis B virus gene expression in trans-formalin in tissue cassettes. Liver pieces in formalin were embedded
genic mice. J. Virol. 66, 3955–3960.in paraffin, cut into 5-micron sections, and stained with hematoxylin
and eosin according to standard protocol. Gilles, P.N., Guerrette, D.L., Ulevitch, R.J., Schreiber, R.D., and Chi-
sari, F.V. (1992b). HBsAg retention sensitizes the hepatocyte to injury
by physiological concentrations of interferon-gamma. HepatologyAcknowledgments
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